SBIR-STTR Award

Augmenting the Quality and Duration of the Immune Response with Anovel TLR2 Agonist-Aluminum Combination Adjuvant
Award last edited on: 7/28/2022

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$300,000
Award Phase
1
Solicitation Topic Code
91
Principal Investigator
Larry C Blaszczak

Company Information

Teichos Laboratories LLC

1281 Win Hentschel Boulevard
Indianapolis, IN 46202
   (317) 370-8059
   bln@teichos-labs.com
   www.teichos-labs.com
Location: Single
Congr. District: 04
County: Marion

Phase I

Contract Number: 75N93021C00057
Start Date: 9/30/2021    Completed: 9/29/2022
Phase I year
2021
Phase I Amount
$300,000
The goal of this project is to optimize a novel adjuvant formulation composed of alum and a TLR2 agonist to improve performance of a DTaP subunit vaccine.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----